Tag: EVS
EVS 2023: Ozsvath assumes Eastern Vascular presidency
Kathleen Ozsvath, MD, a vascular surgeon at St. Peters Health Partners in Albany, New York, took over as president of the Eastern Vascular Society...
Eastern Vascular gathering challenged to forge next generation of evolution
Evolution was the core theme of the Presidential Address Robert Rhee, MD, delivered from the Eastern Vascular Society (EVS) annual meeting stage in Philadelphia...
The top 10 most popular Vascular Specialist stories of October 2022
The most-read Vascular Specialist stories in October covered an investigation of thoracic endovascular aortic repair (TEVAR) timing presented at the Eastern Vascular Society (EVS)...
Slew of regional vascular societies welcome new leaders for 2022–23
A number of regional vascular societies across the U.S. and Canada introduced their 2022–23 slew of officers during their annual meetings across the fall...
EVS 2022: Study suggests lower rates of aortic rupture, mortality after...
Thoracic endovascular aortic repair (TEVAR) carried out for uncomplicated type B aortic dissections (TBAD) saw worse mortality and aortic-related outcomes when performed in the...
Vascular Specialist–October 2022
In this issue:
Regional vascular society presidents measure state of specialty (p. 1 and 4)
Study: Combined antiplatelet, NOAC use linked to worse limb...
New study indicates cost-effectiveness of Denali IVC filter over Option device
Tilting or hooking occurred significantly less often in the process of retrieving the Denali inferior vena cava (IVC) filter than with the Option IVC...
Female sex is associated with reintervention and mortality following elective EVAR
Women are more likely to die within five years of having elective surgery to repair an abdominal aortic aneurysm (AAA) or need repeat surgery, according to...
Regional society leaders look forward to VAM and beyond
We asked the presidents of all five major regional vascular societies in the United States for an update on the latest goings-on in their...
Vascular Specialist–December 2021
In this issue:
*This issue went to press before Congress moved to address cuts to Medicare due to kick in Jan. 1, 2022.
"Countdown to...
PTFE crural bypasses: ‘Very acceptable patency, excellent limb salvage is obtainable...
“The mantra I always use with fellows is bad vein, bad bypass.” Those were the words of Gregg Landis, MD, system chief of vascular...
‘Female sex predicts reintervention after elective EVAR for AAA’
Females were found to be at greater risk of reintervention following elective endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAAs) at both the...
Vascular Specialist–November 2021
In this issue:
"In good hands?" The twin issues of center volumes for open AAA repair as well as training implications came under the...
The top 10 most popular Vascular Specialist stories in September
Five-year data from the ACST-2 trial comparing carotid endarterectomy and carotid artery stenting, a report from the Crawford Forum at the 2021 Vascular Annual...
Vascular Specialist–October 2021
In this issue:
"Not all cuts disappear": We take a look at the threat posed to vascular surgery—and the office-based lab (OBL) setting in...
Registry data show greater clot chronicity on post-procedure inspection than initially...
Nearly half of patients deemed pre-procedurally to be suffering an acute case of deep vein thrombosis (DVT) turned out to have a “much more”...
EVS 2021: Vascular surgery as ‘an enabling service’ for the wider...
Vascular surgery is as important as anesthesia in providing a safe operating room (OR), Richard Powell, MD, the vascular section chief at Dartmouth-Hitchcock Medical...
OBL: Community surgeons discuss surviving private practice in office-based labs
Outpatient settings like office-based laboratories (OBLs) have attracted increased scrutiny in recent times amid efforts to shine greater light on appropriateness in care. During...
Previously described patient-centered clinical success measure after revascularization for diabetic foot...
Patient-centered clinical success after lower-extremity revascularization for people with diabetic foot wounds was achieved among 63% of patients in a new analysis—but researchers suggest...
New analysis finds DCBs lead to greater four-year survival after fempop...
Patients treated with a paclitaxel-coated balloon saw greater survival, freedom from amputation and amputation-free survival through four-year follow-up after their initial femoropopliteal revascularization operation...
September slate of regional vascular meetings goes digital
This time last year, the ranks of vascular surgery were gearing up to head for points East, West, Midwest and Northeast as the slew...